Fate Therapeutics (FATE) Amortization of Deferred Charges (2014 - 2019)
Fate Therapeutics' (FATE) quarterly Amortization of Deferred Charges came in at $68000.0 in Q4 2019, up 257.89% YoY from $19000.0 in Q4 2018, and up 353.33% on a QoQ basis from $15000.0 in Q3 2019.
Powered by 
Analysis
Fate Therapeutics (FATE) Amortization of Deferred Charges (2014 - 2019) Analysis & Trends
Fate Therapeutics (FATE) has 6 years of Amortization of Deferred Charges data on file, last reported at $68000.0 in Q4 2019.
- Quarterly Amortization of Deferred Charges rose 257.89% year-over-year to $68000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $115000.0 (up 51.32% YoY) and the FY2019 annual result came in at $115000.0, up 51.32% from the prior year.
- Amortization of Deferred Charges improved to $68000.0 in Q4 2019, from $15000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $68000.0 in Q4 2019 to a low of $15000.0 in Q1 2019.
- A 5-year average of $29350.0 and a median of $21500.0 in 2017 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2015 — Amortization of Deferred Charges surged 1400.0% — and 2017, when it sank 50.0%.
- Tracing FATE's Amortization of Deferred Charges over 5 years: stood at $44000.0 in 2015, then sank by 36.36% to $28000.0 in 2016, then plunged by 32.14% to $19000.0 in 2017, then changed by 0.0% to $19000.0 in 2018, then jumped by 257.89% to $68000.0 in 2019.
- The last three Amortization of Deferred Charges figures came in at $68000.0 (Q4 2019), $15000.0 (Q3 2019), and $17000.0 (Q2 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Fate Therapeutics | 299.79 Mn | 299.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 68,000.00 |
| Sep 30, 2019 | 15,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | 19,000.00 |
| Sep 30, 2018 | 19,000.00 |
| Jun 30, 2018 | 19,000.00 |
| Mar 31, 2018 | 19,000.00 |
| Dec 31, 2017 | 19,000.00 |
| Sep 30, 2017 | 19,000.00 |
| Jun 30, 2017 | 19,000.00 |
| Mar 31, 2017 | 24,000.00 |
| Dec 31, 2016 | 28,000.00 |
| Sep 30, 2016 | 33,000.00 |
| Jun 30, 2016 | 38,000.00 |
| Mar 31, 2016 | 40,000.00 |
| Dec 31, 2015 | 44,000.00 |
| Sep 30, 2015 | 45,000.00 |
| Jun 30, 2015 | 43,000.00 |
| Mar 31, 2015 | 44,000.00 |